Septerna, Inc.
NASDAQ:SEPNBiotechnology
-$0.73 today
- Market cap
- $1.88B
- Beta
- 2.38
- P/E (TTM)
- -43.6
- EPS (TTM)
- -$0.81
Volume 0.30M
Average 0.32M
SEPN Total Debt
Short-term and long-term borrowings combined.
Septerna, Inc.NASDAQ: SEPN
Total Debt · Q3 FY2026 · quarter ended Sep 2026
Total debt falls 8.8% from a year ago
Total debt stood at $21.99M at the end of Q3 FY2026, down 8.8% from a year earlier and down 2.4% from the prior quarter. Over 3 fiscal years it compounded at +221.6% a year.
Context
- Total debt amounted to 3.6% of total assets at the end of Q3 FY2026, down 0.4 pp from a year earlier.
- Total debt increased in 2 of the last 3 fiscal years.
What to watch
Whether total debt keeps falling in the next quarterly balance sheet after a -8.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Debt history
USD · from the balance sheet
- Latest · FY2025
- 23.63M USD
- Year-over-year change
- -7.3%
- 3-year CAGR
- +221.6%
| Period | Period end | Total Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 23.63M | -7.3% |
| FY2024 | 2024-12-31 | 25.48M | +102.7% |
| FY2023 | 2023-12-31 | 12.57M | +1669.9% |
| FY2022 | 2022-12-31 | 710K | — |
Total Debt vs competitors
How SEPN compares with its peers on the latest reported figures
- SEPN's Sep 2026 total debt of $21.99M is the 2nd highest of the 7 companies compared; the peer median is $4.76M.
- Its year-over-year change of -8.8% is the 3rd highest of 6, against a peer median of -18.9%.
- Total debt amounts to 3.6% of total assets for SEPN, versus a peer median of 0.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $61.22M | +137.1% | -10.1% | 14.6% | |
SEPNSepterna, Inc. | Sep 2026 | $21.99M | -8.8% | +221.6% | 3.6% |
KLRAKailera Therapeutics, Inc. | Jun 2026 | $10.22M | — | — | 0.8% |
| Jun 2026 | $6.23M | -18.9% | +192.2% | 0.4% | |
MBXMBX Biosciences, Inc. Common Stock | Sep 2026 | $3.29M | +428.3% | +8.9% | 0.7% |
| Mar 2026 | $1.24M | -84.4% | -11.4% | 2.7% | |
| Mar 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding SEPN) | $4.76M | -18.9% | -0.6% | 0.8% | |
Competitors are the stored peer set for SEPN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Septerna, Inc.
NASDAQ:SEPN
Intrinsic Alpha fair value
Locked
Current Price
$39.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.